New hope for kids with severe arthritis: drug trial shows promise
NCT ID NCT00339157
Summary
This study tested whether the drug anakinra could help children and young adults with a severe form of juvenile arthritis that wasn't controlled by steroid medications. For the first month, half the 24 participants received anakinra and half received a placebo, followed by 11 months where everyone received the drug. The main goal was to see if anakinra could significantly reduce arthritis activity and allow doctors to lower steroid doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bordeaux CHU
Bordeaux, 33000, France
-
Hopital Lyon Edouard Herriot
Lyon, 69437, France
-
Kremlin-Bicetre Hospital
Paris, 94270, France
-
Nancy Hopital d'Enfants
Nancy, 54511, France
-
Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants Malades Hospital, 149 rue de Sevres
Paris, 75015, France
-
Robert Debre Hospital
Paris, 75019, France
Conditions
Explore the condition pages connected to this study.